Table of Contents Author Guidelines Submit a Manuscript
Arthritis
Volume 2016, Article ID 5371682, 9 pages
http://dx.doi.org/10.1155/2016/5371682
Research Article

Towards Tailored Patient’s Management Approach: Integrating the Modified 2010 ACR Criteria for Fibromyalgia in Multidimensional Patient Reported Outcome Measures Questionnaire

1Rheumatology, Darent Valley Hospital, Dartford DA2 8DA, UK
2Rheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt
3Community, Environmental and Occupational Medicine, Ain Shams University, Cairo, Egypt
4Internal Medicine, Cairo University, Cairo, Egypt

Received 16 November 2015; Accepted 16 March 2016

Academic Editor: Ruben Burgos-Vargas

Copyright © 2016 Yasser El Miedany et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Wolfe, D. J. Clauw, M.-A. Fitzcharles et al., “The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity,” Arthritis Care and Research, vol. 62, no. 5, pp. 600–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Wolfe, H. A. Smythe, M. B. Yunus et al., “The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee,” Arthritis & Rheumatism, vol. 33, no. 2, pp. 160–172, 1990. View at Publisher · View at Google Scholar
  3. F. Wolfe, D. J. Clauw, M.-A. Fitzcharles et al., “Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia,” The Journal of Rheumatology, vol. 38, no. 6, pp. 1113–1122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Wessely and M. Hotopf, “Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence,” Bailliere's Best Practice and Research in Clinical Rheumatology, vol. 13, no. 3, pp. 427–436, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Wolfe, “The status of fibromyalgia criteria,” Arthritis & Rheumatology, vol. 67, no. 2, pp. 330–333, 2015. View at Publisher · View at Google Scholar
  6. J. D. Katz, G. Mamyrova, O. Guzhva, and L. Furmark, “Gender bias in diagnosing fibromyalgia,” Gender Medicine, vol. 7, no. 1, pp. 19–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Yokota, M. Kikuchi, and T. Miyamae, “Juvenile fibromyalgia: guidance for management,” Pediatrics International, vol. 55, no. 4, pp. 403–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Mas, L. Carmona, M. Valverde et al., “Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a natiowide study in Spain,” Clinical and Experimental Rheumatology, vol. 26, no. 4, pp. 519–526, 2008. View at Google Scholar · View at Scopus
  9. S. Kashikar-Zuck and T. V. Ting, “Juvenile fibromyalgia: current status of research and future developments,” Nature Reviews Rheumatology, vol. 10, no. 2, pp. 89–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Lourenço, L. Costa, A. M. Rodrigues, F. Carnide, and R. Lucas, “Gender and psychosocial context as determinants of fibromyalgia symptoms (fibromyalgia research criteria) in young adults from the general population,” Rheumatology, vol. 54, no. 10, pp. 1806–1815, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Rivera, J. Rejas-Gutiérrez, M. A. Vallejo, J. Esteve-Vives, and M. De Salas-Cansado, “Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice,” Clinical and Experimental Rheumatology, vol. 30, no. 6, supplement 74, pp. 31–38, 2012. View at Google Scholar · View at Scopus
  12. S. Silverman, E. M. Dukes, S. S. Johnston, N. A. Brandenburg, A. Sadosky, and D. M. Huse, “The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis,” Current Medical Research and Opinion, vol. 25, no. 4, pp. 829–840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Wolfe, K. Michaud, T. Li, and R. S. Katz, “Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia,” Journal of Rheumatology, vol. 37, no. 2, pp. 305–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Gore, A. Sadosky, G. Zlateva, and D. Clauw, “Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia,” The American Journal of Managed Care, vol. 16, supplement 5, pp. S144–S153, 2010. View at Google Scholar · View at Scopus
  15. D. Buskila, A. Shnaider, L. Neumann, D. Zilberman, N. Hilzenrat, and E. Sikuler, “Fibromyalgia in hepatitis C virus infection: another infectious disease relationship,” Archives of Internal Medicine, vol. 157, no. 21, pp. 2497–2500, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. Ö. N. Pamuk and N. Çakir, “The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms,” Clinical Rheumatology, vol. 26, no. 1, pp. 55–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Arnold, J. I. Hudson, P. E. Keck Jr., M. B. Auchenbach, K. N. Javaras, and E. V. Hess, “Comorbidity of fibromyalgia and psychiatric disorders,” Journal of Clinical Psychiatry, vol. 67, no. 8, pp. 1219–1225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. M. Arnold, J. I. Hudson, E. V. Hess et al., “Family study of fibromyalgia,” Arthritis and Rheumatism, vol. 50, no. 3, pp. 944–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Thieme, D. C. Turk, and H. Flor, “Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables,” Psychosomatic Medicine, vol. 66, no. 6, pp. 837–844, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Ruta, A. M. Garratt, and I. T. Russell, “Patient centred assessment of quality of life for patients with four common conditions,” Quality in Health Care, vol. 8, no. 1, pp. 22–29, 1999. View at Google Scholar · View at Scopus
  21. A. Bowling, Research Methods in Health. Investigating Health and Health Services, Open University Press, Buckingham, UK, 1997.
  22. A. M. Garratt and D. A. Ruta, “The patient generated index,” in Individual Quality of Life: Approaches to Conceptualisation and Assessment, C. R. B. Joyce, C. A. O'Boyle, and H. M. Mcgee, Eds., pp. 105–118, Harwood Academic Publishers, Amsterdam, The Netherlands, 1999. View at Google Scholar
  23. J. M. Linacre, “Understanding Rasch measurement: estimation methods for Rasch measures,” Journal of outcome measurement, vol. 3, no. 4, pp. 382–405, 1999. View at Google Scholar · View at Scopus
  24. Y. El Miedany, M. El Gaafary, S. S. Youssef, and D. Palmer, “Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis,” Clinical and Experimental Rheumatology, vol. 28, no. 5, pp. 734–744, 2010. View at Google Scholar · View at Scopus
  25. D. Wood, R. Wray, N. Poulter et al., “Joint British societies' guidelines on prevention of cardiovascular disease in clinical practice,” Heart, vol. 91, supplement 5, pp. v1–v52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, “Measurement of patient outcome in arthritis,” Arthritis and Rheumatism, vol. 23, no. 2, pp. 137–145, 1980. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Parkin, N. Rice, and N. Devlin, “Statistical analysis of EQ-5D profiles: does the use of value sets bias inference?” Medical Decision Making, vol. 30, no. 5, pp. 556–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. El Miedany, M. El Gaafary, M. Toth, D. Palmer, and I. Ahmed, “Falls risk assessment score (FRAS): time to rethink,” Journal of Clinical Gerontology and Geriatrics, vol. 2, no. 1, pp. 21–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M.-A. Fitzcharles, P. A. Ste-Marie, D. L. Goldenberg et al., “2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary,” Pain Research and Management, vol. 18, no. 3, pp. 119–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. T. Kane, “Validation,” in Educational Measurement, R. L. Brennan, Ed., vol. 4, pp. 17–64, American Council on Education/Praeger Publishers, Westport, Conn, USA, 2006. View at Google Scholar
  31. R. M. Bennett, R. Friend, K. D. Jones, R. Ward, B. K. Han, and R. L. Ross, “The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties,” Arthritis Research and Therapy, vol. 11, no. 4, article R120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. N. Ablin, L. Odes, L. Neumann, and D. Buskila, “The Hebrew version of the FibroFatigue scale: validation of a questionnaire for assessment of fibromyalgia and chronic fatigue syndrome,” Rheumatology International, vol. 30, no. 9, pp. 1173–1176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. S. Boomershine, B. Emir, G. Zlateva, and Y. Wang, “Simplifying fibromyalgia assessment: the VASFIQ brief symptom scale,” Therapeutic Advances in Musculoskeletal Disease, vol. 3, no. 5, pp. 215–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Brand, G. Littlejohn, L. Kristjanson, S. Wisniewski, and T. Hassard, “The fibromyalgia bladder index,” Clinical Rheumatology, vol. 26, no. 12, pp. 2097–2103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Rivera and T. Gonzalez, “The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia,” Clinical and Experimental Rheumatology, vol. 22, no. 5, pp. 554–560, 2004. View at Google Scholar
  36. A. Finckh, A. Morabia, C. Deluze, and T. Vischer, “Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome,” Arthritis Care and Research, vol. 11, no. 2, pp. 116–123, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Sarzi-Puttini, F. Atzeni, M. Turiel et al., “The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms,” Journal of Psychosomatic Research, vol. 56, no. 2, pp. 213–216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. Bennett, J. Jones, D. C. Turk, I. J. Russell, and L. Matallana, “An internet survey of 2,596 people with fibromyalgia,” BMC Musculoskeletal Disorders, vol. 8, article 27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Wright, “Widespread body pain and mortality. Diagnosing fibromyalgia stops doctors from thinking,” BMJ, vol. 324, no. 7332, p. 300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Orellana, E. Casado, M. Masip, C. Galisteo, J. Gratacós, and M. Larrosa, “Sexual dysfunction in fibromyalgia patients,” Clinical and Experimental Rheumatology, vol. 26, no. 4, pp. 663–666, 2008. View at Google Scholar · View at Scopus
  41. R. Bennett, “The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses,” Clinical and Experimental Rheumatology, vol. 23, no. 5, supplement 39, pp. S154–S162, 2005. View at Google Scholar · View at Scopus
  42. R. M. Bennett, R. Friend, K. D. Jones, R. Ward, B. K. Han, and R. L. Ross, “The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties,” Arthritis Research & Therapy, vol. 11, no. 4, article R120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Vallejo, J. Rivera, J. Esteve-Vives, and J. Rejas, “A confirmatory study of the combined index of severity of fibromyalgia (ICAF): factorial structure, reliability and sensitivity to change,” Health and Quality of Life Outcomes, vol. 9, article 39, 2011. View at Publisher · View at Google Scholar · View at Scopus